RGX-019-MMAE inhibits leukemia progression by targeting MER proto-oncogene tyrosine kinase (MERTK) in acute myeloid leukemia

Abstract Background Myeloid epithelial reproductive tyrosine kinase (MERTK) receptor is overexpressed in cancers and is associated with poor prognosis. RGX-019-MMAE, a novel humanized IgG1-MMAE antibody-drug conjugate (ADC) (Inspirna, Inc), selectively binds to MERTK with high affinity, resulting in...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Anudishi Tyagi, Maryam Siddiqui, Amanda Eckstrom, Isabel Kurth, Shugaku Takeda, Priyanka Sharma, Gautam Borthakur, Bin Yuan, Hussein A. Abbas, Vivek Anand, Jenny Borgman, Steven Kornblau, Abhishek Maiti, V. Lokesh Battula
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2026-03-01
coleção:	Journal of Experimental & Clinical Cancer Research
Assuntos:	Myeloid epithelial tyrosine kinase (MERTK) Antibody drug conjugate (ADC) Monomethyl auristatin e (MMAE) Reverse phase protein arrays (RPPA) Acute myeloid leukemia (AML)
Acesso em linha:	https://doi.org/10.1186/s13046-026-03657-y
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!